Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways

Oncogene

Volumn 25, Issue 35, 2006, Pages 4857-4866

  Wang, T H ^a   Chan, Y H ^a   Chen, C W ^a   Kung, W H ^a   Lee, Y S ^a,b   Wang, S T ^c   Chang, T C ^a   Wang, H S ^a,d,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b MING CHUAN UNIVERSITY   (Taiwan)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Interleukin 6 (IL 6); JNK; Paclitaxel; Taxol

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COMPLEMENTARY DNA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PACLITAXEL; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; PACLITAXEL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 33746877876     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209498     Document Type: Article

References (56)

1. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y et al. (1990). EMBO J 9: 1897-1906.
2. Baffet G, Braciak TA, Fletcher RG, Gauldie J, Fey GH, Northemann W. (1991). Mol Biol Med 8: 141-156.
3. Bain J, McLauchlan H, Elliott M, Cohen P. (2003). Biochem J 371: 199-204.
4. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. (2001). Proc Natl Acad Sci USA 98: 13681-13686.
5. Blagosklonny MV, Fojo T. (1999). Int J Cancer 83: 151-156.
6. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG et al. (2001). Proc Natl Acad Sci USA 98: 9824-9829.
7. Churchill GA. (2002). Nat Genet 32: 490-495.
8. Cui X, Churchill GA. (2003). Genome Biol 4: 210.
9. Das KC, White CW. (1997). J Biol Chem 272: 14914-14920.
10. Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF et al. (2003). Clin Cancer Res 9: 1557-1565.
11. Ding AH, Porteu F, Sanchez E, Nathan CF. (1990). Science 248: 370-372.
12. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T et al. (2002). Oncogene 21: 6510-6519.
13. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL et al. (2004). J Biol Chem 279: 11957-11966.
14. Duan Z, Feller AJ, Penson RT, Chabner BA, Seiden MV. (1999). Clin Cancer Res 5: 3445-3453.
15. Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX et al. (2004). J Biol Chem 279: 9653-9661.
16. Flynn Jr V, Ramanitharan A, Moparty K, Davis R, Sikka S, Agrawal KC et al. (2003). Int J Oncol 23: 317-323.
17. Gorgoni B, Caivano M, Arizmendi C, Poli V. (2001). J Biol Chem 276: 40769-40777.
18. Hefler LA, Grimm C, Ackermann S, Malur S, Radjabi-Rahat AR, Leodolter S et al. (2003). Cancer Res 63: 3066-3068.
19. Huang Y, Fan W. (2002). Mol Pharmacol 61: 105-113.
20. Jordan MA, Wilson L. (2004). Nat Rev Cancer 4: 253-265.
21. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. (2000). J Biol Chem 275: 2251-2254.
22. Kawasaki K, Nogawa H, Nishijima M. (2003). J Immunol 170: 413-420.
23. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. (2001). Chem Biol 8: 759-766.
24. Lanni JS, Lowe SW, Licitra EJ, Liu JO, Jacks T. (1997). Proc Natl Acad Sci USA 94: 9679-9683.
25. Lee LF, Haskill JS, Mukaida N, Matsushima K, Ting JP. (1997). Mol Cell Biol 17: 5097-5105.
26. Lee LF, Li G, Templeton DJ, Ting JP. (1998). J Biol Chem 273: 28253-28260.
27. Lee LF, Schuerer-Maly CC, Lofquist AK, van Haaften-Day C, Ting JP, White CM et al. (1996). Cancer Res 56: 1303-1308.
28. Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK et al. (2005). BMC Genomics 6: 1-10.
29. Li BY, Mohanraj D, Olson MC, Moradi M, Twiggs L, Carson LF et al. (1992). Cancer Res 52: 2248-2252.
30. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP et al. (2004). J Biol Chem 279: 24015-24023.
31. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A et al. (2004). Cancer Res 64: 1655-1663.
32. Liu ZG, Hsu H, Goeddel DV, Karin M. (1996). Cell 87: 565-576.
33. Livak KJ, Schmittgen TD. (2001). Methods 25: 402-408.
34. MacKeigan JP, Collins TS, Ting JP. (2000). J Biol Chem 275: 38953-38956.
35. Meikrantz W, Schlegel R. (1996). J Biol Chem 271: 10205-10209.
36. Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL. (2004). Oncogene 23: 596-604.
37. Nakshatri H, Rice SE, Bhat-Nakshatri P. (2004). Oncogene 23: 7330-7344.
38. Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE et al. (2000). Int J Gynecol Cancer 10: 33-41.
39. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM et al. (2001). J Immunol 166: 574-581.
40. Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J et al. (2004). Cytokine 25: 94-102.
41. Rosette C, Karin M. (1995). J Cell Biol 128: 1111-1119.
42. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS. (2003). Cancer Res 63: 2948-2956.
43. Takeda K, Kaisho T, Akira S. (2003). Annu Rev Immunol 21: 335-376.
44. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N et al. (1995). Cell 80: 353-361.
45. Taxman DJ, MacKeigan JP, Clements C, Bergstralh DT, Ting JP. (2003). Cancer Res 63: 5095-5104.
46. Uematsu S, Matsumoto M, Takeda K, Akira S. (2002). J Immunol 168: 5811-5816.
47. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N et al. (2002). Clin Cancer Res 8: 3579-3583.
48. Villunger A, Egle A, Kos M, Hittmair A, Maly K, Greil R. (1996). Int J Cancer 65: 498-505.
49. Vivat-Hannah V, You D, Rizzo C, Daris JP, Lapointe P, Zusi FC et al. (2001). Cancer Res 61: 8703-8711.
50. Wang TH, Lee YS, Chen ES, Kung WH, Chen LK, Hsueh DW et al. (2004). Chang Gung Med J 27: 243-260.
51. Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC et al. (1999). J Biol Chem 274: 8208-8216.
52. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T et al. (1998). J Biol Chem 273: 4928-4936.
53. Wang TH, Wang HS, Soong YK. (2000). Cancer 88: 2619-2628.
54. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. (1990). Cancer Res 50: 6959-6965.
55. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN et al. (2003). Oncogene 22: 1517-1527.
56. Yusuf RZ, Duan Z, Lamendola DE, Penson RT, Seiden MV. (2003). Curr Cancer Drug Targets 3: 1-19.